Eppley Institute to host short course in cancer biology

Bill Hahn, M.D., Ph.D., will be one of the speakers at the event.

The Eppley Institute for Research in Cancer and Allied Diseases will host a “Short Course in Cancer Biology: Drug Resistance in Cancer” on June 11-12 at the Fred & Pamela Buffett Cancer Center’s Yanney Conference Center.

Ken Cowan, M.D., Ph.D., will deliver a welcome message at 8:30 a.m. June 11 to begin the conference. Xu Luo, Ph.D., associate professor at the Eppley Institute, will host the conference.

Speakers will include:

June 11
Trever Bivona, M.D., Ph.D., University of California San Francisco
“Therapeutic Strategies to Forestall the Evolution of Drug Resistance in Lung Cancer”
Lecture: 8:45- 9:45 a.m.
Lecture: 10-11 a.m.
Discussion: 11:05 a.m.-11:45 a.m., featuring Dr. Bivona, Roger Lo, M.D., Ph.D., Bill Hahn, M.D., Ph.D., and Channing Der, Ph.D.

Roger Lo, M.D., Ph.D., University of California Los Angeles

“Therapies for Melanoma Based on Resistance Mechanism”
Lecture: 1:30-2:30 p.m.
Lecture: 2:45-3:45 p.m.
Discussion: 4-4:45 p.m., featuring Drs. Lo, Hahn and Der

June 12
Bill Hahn, M.D., Ph.D., Dana Farber Cancer Institute, Harvard Medical School
“Defining a Cancer Dependency Map for Precision Cancer Medicine”
Lecture: 8:45-9:45 a.m.
Lecture: 10-11 a.m.
Discussion: 11:05- 11:45 a.m., featuring Drs. Hahn and Der

Channing Der, Ph.D., University of North Carolina
“Targeting Undruggable RAS for Cancer Treatment”
Lecture: 1-2 p.m.
Lecture: 2:10-3:10 p.m.
Discussion: 3:15-4 p.m., featuring Drs. Hahn and Der.

For more information, contact Misty Pocwierz-Gaines at 559-4092.